Sachetta, LLC Keros Therapeutics, Inc. Transaction History
Sachetta, LLC
- $253 Billion
- Q2 2025
A detailed history of Sachetta, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Sachetta, LLC holds 244 shares of KROS stock, worth $3,350. This represents 0.0% of its overall portfolio holdings.
Number of Shares
244
Previous 244
-0.0%
Holding current value
$3,350
Previous $2.49 Million
31.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KROS
# of Institutions
182Shares Held
36.5MCall Options Held
938KPut Options Held
1.39M-
Vanguard Group Inc Valley Forge, PA2.63MShares$36.1 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$35.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$34.5 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$27.5 Million3.97% of portfolio
-
Morgan Stanley New York, NY1.7MShares$23.3 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $354M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...